Last Updated On 9/9/2024 11:00:30 PM
This is a disclosure report of the user financial relationships with for-profit health care companies.
All relationships are considered compensated unless otherwise noted. Relationships are self-held unless otherwise noted.
Employment |
Company: Merck |
Recipient: An Immediate Family Member |
|
Leadership |
No Relationships to Disclose |
|
|
Stock and Other Ownership Interests |
Company: Merck |
Recipient: An Immediate Family Member |
Company: Ibris |
Recipient: You |
Company: Inspirata |
Recipient: You |
Company: Silagene |
Recipient: You |
|
Honoraria |
No Relationships to Disclose |
|
|
Consulting or Advisory Role |
Company: Inspirata |
Recipient: You |
Company: Novartis |
Recipient: You |
Company: Roche |
Recipient: You |
Company: Foghorn Therapeutics |
Recipient: You |
Company: Foundation Medicine |
Recipient: You |
Company: Merck Sharp & Dohme |
Recipient: You |
Company: Silagene |
Recipient: You |
Company: EQRx |
Recipient: You |
Company: EMD Serono |
Recipient: You |
Company: KayoThera |
Recipient: You |
Company: Ipsen |
Recipient: You |
|
Speakers' Bureau |
No Relationships to Disclose |
|
|
Research Funding |
Company: M2Gen |
Recipient: Your Institution |
Company: Gandeeva Therapeutics |
Recipient: Your Institution |
|
Patents, Royalties, Other Intellectual Property |
Please describe: I hold 2 patents for digital imaging that may be lisenced to Ibris, inc and Inspirata, Inc. |
Recipient: You |
|
Expert Testimony |
No Relationships to Disclose |
|
|
Travel, Accommodations, Expenses |
No Relationships to Disclose |
|
|
Other Relationship |
Company: NCI/NIH |
Recipient: You |
Company: NCI/NIH |
Recipient: You |
|
(OPTIONAL) Uncompensated Relationships |
No Relationships to Disclose |
|
|
(OPTIONAL) Open Payments Link |
not answered |
|
|